The Director, Office of Generic Animal Drugs (OGAD), is the principal advisor to the Center Director, Center for Veterinary Medicine (CVM), providing expert-level administrative, scientific, and regulatory authority for CVM on matters related to pre-market review of generic animal drugs. Assists the Center Director on security intelligence matters involving OGAD; accessing classified information in written and/or electronic formats and requiring Top Secret Clearance. The incumbent provides scientific, administrative, and regulatory leadership and direction through subordinate division directors for FDA's pre-market generic animal drug regulatory program activities. This is a remote position.
Application Period:11/22/2024-12/06/2024
Location: Rockville, Maryland
Qualifications To be placed into a Cures position, candidates must meet the following criteria: 1. Scientific, Technical, and Professional Fields 2. Qualified and Outstanding Candidates a. Qualified applies to all candidates for Cures appointments. The FDA OTS will use the basic requirements defined in the OPM Qualification Standards as a baseline for comparing experience levels and other candidate attributes for relevant positions. b. Outstanding candidates can be defined by existing outstanding work experience, outstanding performance rating, or both. In order to qualify for this Title 21 Cures position, the candidate(s) must meet the following required qualifications. Please note: Additional education and experience listed that is not indicated as required is preferable and desired. Candidates who do not meet the “desired” criteria will not be excluded from consideration for this position.
Education Requirement: Series: 0701 Degree: Doctor of Veterinary Medicine (DVM) or equivalent degree, i.e., Veterinary Medical Doctor (VMD), obtained at a school or college of veterinary medicine accredited by the American Veterinary Medical Association Council on Education (AVMA). The AVMA web site, http://www.avma.org(external link), has a listing of all AVMA-accredited veterinary medical schools. OR Graduates of foreign veterinary medical schools that are not accredited by the AVMA Council on Education (Refer to AVMA web site, http://www.avma.org (external link) for information.
The mission statement for FDA’s Center for Veterinary Medicine (CVM) reads, “Protecting Human and Animal Health.” To achieve this broad mission, CVM:
Ensures animal drugs are safe and effective, properly made, and adequately labeled and packaged;
Ensures that when food-producing animals, such as cattle and chickens, are treated with an animal drug, food made from those animals, such as meat, milk, and eggs, are safe for people to eat;
Ensures that new animal food additives are safe and serve their intended function;
Educates pet owners, animal producers, veterinarians, and the animal health industry about the products we regulate;
Monitors the safety of all types of animal food for all types of animals;
Monitors and investigates side effects and product quality problems that are reported for animal food, drugs, and devices (like thermometers and pacemakers) once they are sold on the market;
Carries out research to support our policies and regulatory decisions about animal food, drugs, and devices;
Works to make more animal drugs legally available for minor species, such as ferrets and fish; and for minor (infrequent and limited) uses in a major species, such as horses an...d dogs;
Works to support and spur the development of new technologies and approaches that address health needs across human, animal and environmental health sectors; and
Leads, coordinates, and manages CVM’s international activities in collaboration with relevant FDA Centers and Offices, as well as FDA’s international regulatory counterparts.